Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Xenium Protein, a ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive ...

An exclusive interview with Serge Saxonov of 10x Genomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.

Breakthrough advancements in workflow efficiency, AI integration, and precision medicine applications fuel growth across oncology, immunology, and in ...

Biotech company 10x Genomics (NASDAQ:TXG) in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand ...

Genomics (TXG) announced that it has signed a definitive agreement to acquire Scale Biosciences, a company in innovative and scalable single ...

New single cell and spatial innovations extend 10x Genomics’ technology and performance TrendingAstoria has a new schoolMeet the man working to turn Clatsop County redleadership across all three ...

New single cell and spatial innovations extend 10x Genomics’ technology and performance leadership across all three platforms PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances ...

Feb. 23, 2025 11:30 AM ET 10x Genomics, Inc. (TXG) New single cell and spatial innovations extend 10x Genomics' (TXG) technology and performance leadership across all three platforms ...